Article

Efgartigimod for Generalized Myasthenia Gravis and Beyond: A Narrative Review of its Pharmacological Profile, Clinical Utility, and Expanding Applications

2025-11-07

Abstract excerpt

Efgartigimod is a novel neonatal Fc receptor (FcRn) antagonist that reduces pathogenic IgG autoantibodies, offering a targeted therapeutic approach for generalized myasthenia gravis (gMG) and other antibody-mediated autoimmune diseases. This narrative review synthesizes clinical trial data, pharmacological insights, and real-world evidence to evaluate efgartigimod's efficacy, safety, and emerging applications. Pha...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: eef1dfa2-0e3c-5382-8a48-f9d2bf1bcb64
DOI: 10.20944/preprints202511.0402.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Efgartigimod for Generalized Myasthenia Gravis and Beyond: A Narrative Review of its Pharmacological Profile, Clinical Utility, and Expanding ApplicationsDOI 10.20944/preprints202511.0402.v1Read

Real-World Case Series of Efgartigimod for Generalized Myasthenia Gravis：Well-Tailored Treatment Cycle Intervals Contribute to Sustained Symptom ControlSemantic proximity Read

Efgartigimod efficacy and safety in refractory Myasthenia Gravis - UK’s first real-world experienceSemantic proximity Read

Exploring Myasthenia Gravis Subtypes: Impact on Pregnancy and Recent Treatment AdvancementsSemantic proximity Read

Clinical characteristics and outcome of treatment-refractory myasthenia gravis -a retrospective studySemantic proximity Read

Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets.Semantic proximity Read

Spotlight on MuSK Positive Myasthenia Gravis: Clinical Characteristics, Treatment and OutcomesSemantic proximity Read

Early Versus Delayed Add-on Therapy in Generalized Myasthenia Gravis: A Multicenter Real-World Cohort StudySemantic proximity Read

Clinical Genomic, phenotype and epigenetic insights into the pathology, autoimmunity and weight management of patients with Myasthenia Gravis (Review).Semantic proximity Read

A Retrospective Longitudinal Cohort Study of The Clinical Burden in Myasthenia GravisSemantic proximity Read

Clinical and Demographic Features of Distal Extremity Weakness in Myasthenia Gravis - A Scoping ReviewSemantic proximity Read

Distribution and Temporal Changes of Autoantibody-Mediated Pathogenic Mechanisms Among Acetylcholine Receptor-Positive Myasthenia Gravis PatientsSemantic proximity Read

Myasthenia gravis and related disorders: Pathology and molecular pathogenesisSemantic proximity Read